Adaptimmune Therapeutics plc (ADAP) has a market capitalization of $75.16M and trades at $0.05. The 52-week range is 0.0202-0.86.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -0.2, Earnings Per Share (EPS) of $-0.28, annual revenue of $178.03M.
The stock has a beta of 2.49, operates in the Healthcare sector.
